Latest News - Allergan

Tuesday, January 22, 2019 | PracticalDermatology.com, PracticalDermatology.com, Research and Publications, AAFPRS, Allergan , Cosmetic surgery, Evolus, Galderma, Male aesthetics, Microneedling, Millennials

AAFPRS 2018 Stats: Rhinoplasty Reigns Supreme, Millennials Are The New Influencers, Plus More

Seventy-two percent of facial plastic surgeons saw an increase in cosmetic surgery or injectables in patients under age 30 in 2018, a significant increase from 2017, where over half of members noted t…

Read the full story

Wednesday, January 16, 2019 | Personnel/Company News, PracticalDermatology.com, Allergan , Cool Sculpting, Cynosure, Male aesthetics, RealSelf, Submental fullness, Ulthera

#RealDealAesthetics Tackles Minimally Invasive Body Contouring

Save the date:  Modern Aesthetics’® newest Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist To…

Read the full story

Tuesday, January 15, 2019 | Personnel/Company News, Product Launches and Updates, Allergan , Cool Sculpting

Real Housewife of NYC Sonja Morgan Named New Coolsculpting Spokesperson

Bravo's "The Real Housewives of New York City” Sonja Morgan is the face of Coolscuplting’s new "Let's Get Real About Self-Care" campaign. Morgan joins CoolSculpti…

Read the full story

Wednesday, December 19, 2018 | FDA Approval/Clearance, Product Launches and Updates, Allergan

Allergan Withdraws Sales of Textured Breast Implants, Tissue Expanders in Europe

Allergan is suspending sales of textured breast implants and tissue expanders and is withdrawing any remaining supply in European markets. The withdrawal decision follows a compulsory recall reques…

Read the full story

Tuesday, October 23, 2018 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Allergan , Cool Sculpting

Sex and the City’s Kristin Davis Partners with Coolsculpting for Denim Denial Program

"Sex and the City” star Kristin Davis, is partnering with CoolSculpting for the new "Denim Denial" consumer program.Denim Denial recognizes that every woman has a pair of jeans on…

Read the full story

Wednesday, October 03, 2018 | PracticalDermatology.com, Product Launches and Updates, Allergan

Introducing Juvéderm It, Allergan’s Newest Ad Campaign

Allergan plc is rolling out a new Juvéderm advertising campaign that aims to make this family of fillers a household name. Comprising a modernized logo, a bright, poppy color scheme, an edgy…

Read the full story

Wednesday, September 19, 2018 | Acquisitions and Mergers, PracticalDermatology.com, Product Launches and Updates, Allergan , Bonti

Special Report: Behind Allergan’s and Bonti’s Headline-Making Deal

The race was on. After years of dormancy in the neuromodulator category, at least three novel toxins -- Evolus’ DWP-450, Revance’s daxibotulinumtoxinA, and Bonti’s EB-001 -- were co…

Read the full story

Monday, September 17, 2018 | PracticalDermatology.com, Allergan

Allergan Shares Results of Higher Dose Botox Cosmetic for the Treatment Glabellar Lines

Allergan plc  clinical study results of higher doses of Botox Cosmetic compared to Botox Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar lines. Allergan co…

Read the full story

Friday, September 14, 2018 | Acquisitions and Mergers, PracticalDermatology.com, Allergan , Bonti

Allergan Acquires Bonti for $195M

Allergan acquired Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs for aesthetic and therap…

Read the full story

Wednesday, September 12, 2018 | Healthcare Trends, Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Allergan

Inside Spotlyte: Allergan's Digital Hub to Educate Consumers About Medical Aesthetic Treatments

Allergan has launched Spotlyte, described as an innovative digital hub of curated content that helps consumers discover how medical aesthetic treatments may fit into their routines. Spotlyte is t…

Read the full story

Thursday, May 31, 2018 | Personnel/Company News, PracticalDermatology.com, Research and Publications, Allergan , Cool Sculpting

Allergan Survey: One of Two Latina Influencers Favor Complementing Diet and Exercise with Non-Surgical Body Contouring

More than 50 percent of Latina Influencers think that non-surgical body contouring works well with diet and exercise, according to an Allergan-sponsored survey. The survey results were part of a pa…

Read the full story

Tuesday, May 08, 2018 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Allergan , SkinMedica

Carrie Strom is Allergan’s New Senior Vice President, U.S. Medical Aesthetics

Carrie Strom is Allergan’s new Senior Vice President, U.S. Medical Aesthetics, a portfolio of brands including BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® Collection of Filler…

Read the full story

Wednesday, January 31, 2018 | Personnel/Company News, Product Launches and Updates, Allergan , Cool Sculpting

Cool New Coolsculpting Campaign to Feature Professional Male Athlete Brand Ambassadors

Allergan’s new "Not Cool vs. Cool" Multi-Channel Campaign for CoolSculpting® stars Professional Athlete Brand Ambassadors: Figure Skater Johnny Weir and Golfer Ian P…

Read the full story

Tuesday, December 12, 2017 | FDA Approval/Clearance, Allergan

CoolSculpting is Now FDA Approved to Improve Lax Tissue in Double Chin

The FDA has approved CoolSculpting treatment for the improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments.  Allergan's CoolSculpting for the double …

Read the full story

Tuesday, October 03, 2017 | FDA Approval/Clearance, Allergan

FDA Approves Botox Cosmetic for Moderate to Severe Forehead Lines

The FDA approved Allergan plc's Botox Cosmetic for its third indication, the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity …

Read the full story
Load More